The findings were promising: Improved Erectile Function: Men receiving bremelanotide (at doses 7.5 mg and above) showed statistically significant improvements in erectile function scores (IIEF) compared to placebo.In particular, doses of 7.5, 10, 12.5, and 15 mg were all associated with better International Index of Erectile Function outcomes than placebo.This indicated a dose-dependent efficacy, with higher intranasal doses yielding better erections
Over the 24-week study period, participants received the GLP-1 agonist liraglutide with gradual increments to three mg/day, continuous positive airway pressure (CPAP), or both
But since the causes of low desire can be complex, there isnt a one-size-fits-all treatment
IGF-1 LR3 exhibits additive effects with anabolic steroids and GH by converging on mTOR and satellite cell activation pathways. Schiaffino, S
Chad Walding, DPT, verifiable through brand's About/bio content)
Faria, C